Zacks.com on MSN
3 MedTech Stocks Poised to Gain in 2026 From the AI Boom
AI is reshaping MedTech, and Stryker, Tempus AI and GE HealthCare are emerging as key players leveraging AI across surgery, ...
Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens.
2don MSN
Researchers demonstrate breakthroughs in cancer treatment quality through AI-enhanced data analytics
Cancer researchers at the University of Tennessee Health Science Center have published three new studies demonstrating how ...
Generative AI in healthcare refers to advanced algorithms capable of generating new, original medical data or insights by learning patterns from existing datasets. These systems utilize deep learning ...
In 2025, drug approvals widen treatment options for chronic diseases, infections and pain, including Ozempic kidney ...
SAS predicts the path for data and AI to reshape how the industry discovers, treats and delivers careMarlow, UK (December 16, 2025) – As we step into 2026, the AI and analytics story for health care ...
The Life Science Community(TM), a leading B2B digital media platform serving the pharma, biotech, medtech, healthcare and research industries, today released its Xtalks 2025 Wrapped report, ...
Put the pieces together and you can see a plausible near-future where human scientists focus more on choosing good questions and interpreting results, while an invisible layer of AI systems handles ...
Lords Mark Industries Ltd. receives license to manufacture AI-Based Smart Hemodialysis Machines, boosting India's healthcare self-reliance.
ZURICH, Dec. 18, 2025 /PRNewswire/ -- Switzerland Global Enterprise (S-GE) and Presence Switzerland announced that 24 Swiss high-tech companies will showcase pioneering innovations at CES 2026 in Las ...
NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered ...
SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results